AI-generated summary
This review article surveys the current literature on advanced treatment options for vitiligo, including 308-nm excimer laser, monobenzyl ether of hydroquinone depigmentation, microdermabrasion, micropigmentation, khellin-UVA therapy, and surgical grafting methods. The authors report that successful treatment, even in patients who did not respond to pharmacologic therapy, can be achieved with appropriate patient selection and careful application of these therapies. The abstract does not report pooled outcome data.
- Who or what was studied
- Patients with vitiligo who do not respond to traditional pharmacologic treatments
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The abstract describes a narrative review and does not report the number of included studies, pooled effect sizes, or certainty of evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.